Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1226

1.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2018 Dec 10. pii: S0140-6736(18)33003-4. doi: 10.1016/S0140-6736(18)33003-4. [Epub ahead of print]

PMID:
30545780
2.

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.

Tessoulin B, Moreau-Aubry A, Descamps G, Gomez-Bougie P, Maïga S, Gaignard A, Chiron D, Ménoret E, Le Gouill S, Moreau P, Amiot M, Pellat-Deceunynck C.

J Hematol Oncol. 2018 Dec 13;11(1):137. doi: 10.1186/s13045-018-0679-0.

3.

p53 regulates CD46 expression and measles virus infection in myeloma cells.

Lok A, Descamps G, Tessoulin B, Chiron D, Eveillard M, Godon C, Le Bris Y, Vabret A, Bellanger C, Maillet L, Barillé-Nion S, Gregoire M, Fonteneau JF, Le Gouill S, Moreau P, Tangy F, Amiot M, Moreau-Aubry A, Pellat-Deceunynck C.

Blood Adv. 2018 Dec 11;2(23):3492-3505. doi: 10.1182/bloodadvances.2018025106.

4.

Fungal Planet description sheets: 716-784.

Crous PW, Wingfield MJ, Burgess TI, Hardy GESJ, Gené J, Guarro J, Baseia IG, García D, Gusmão LFP, Souza-Motta CM, Thangavel R, Adamčík S, Barili A, Barnes CW, Bezerra JDP, Bordallo JJ, Cano-Lira JF, de Oliveira RJV, Ercole E, Hubka V, Iturrieta-González I, Kubátová A, Martín MP, Moreau PA, Morte A, Ordoñez ME, Rodríguez A, Stchigel AM, Vizzini A, Abdollahzadeh J, Abreu VP, Adamčíková K, Albuquerque GMR, Alexandrova AV, Álvarez Duarte E, Armstrong-Cho C, Banniza S, Barbosa RN, Bellanger JM, Bezerra JL, Cabral TS, Caboň M, Caicedo E, Cantillo T, Carnegie AJ, Carmo LT, Castañeda-Ruiz RF, Clement CR, Čmoková A, Conceição LB, Cruz RHSF, Damm U, da Silva BDB, da Silva GA, da Silva RMF, de A Santiago ALCM, de Oliveira LF, de Souza CAF, Déniel F, Dima B, Dong G, Edwards J, Félix CR, Fournier J, Gibertoni TB, Hosaka K, Iturriaga T, Jadan M, Jany JL, Jurjević Ž, Kolařík M, Kušan I, Landell MF, Leite Cordeiro TR, Lima DX, Loizides M, Luo S, Machado AR, Madrid H, Magalhães OMC, Marinho P, Matočec N, Mešić A, Miller AN, Morozova OV, Neves RP, Nonaka K, Nováková A, Oberlies NH, Oliveira-Filho JRC, Oliveira TGL, Papp V, Pereira OL, Perrone G, Peterson SW, Pham THG, Raja HA, Raudabaugh DB, Řehulka J, Rodríguez-Andrade E, Saba M, Schauflerová A, Shivas RG, Simonini G, Siqueira JPZ, Sousa JO, Stajsic V, Svetasheva T, Tan YP, Tkalčec Z, Ullah S, Valente P, Valenzuela-Lopez N, Abrinbana M, Viana Marques DA, Wong PTW, Xavier de Lima V, Groenewald JZ.

Persoonia. 2018 Dec;40:240-393. doi: 10.3767/persoonia.2018.40.10. Epub 2018 Jul 13.

5.

A 4 or 5 Deauville score assessed by (18)F-FDG-PET CT early post-allotransplant is highly predictive of relapse in lymphoma patients.

Bouard L, Bodet-Milin C, Bailly C, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Bonnet A, Béné MC, Gouill SL, Moreau P, Kraeber-Bodéré F, Chevallier P.

Biol Blood Marrow Transplant. 2018 Nov 24. pii: S1083-8791(18)30752-3. doi: 10.1016/j.bbmt.2018.11.019. [Epub ahead of print]

PMID:
30481598
6.

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.

Usmani SZ, Hoering A, Cavo M, Miguel JS, Goldschimdt H, Hajek R, Turesson I, Lahuerta JJ, Attal M, Barlogie B, Lee JH, Kumar S, Lenhoff S, Morgan G, Rajkumar SV, Durie BGM, Moreau P.

Blood Cancer J. 2018 Nov 23;8(12):123. doi: 10.1038/s41408-018-0155-7.

7.

Cellular tension encodes local Src-dependent differential β1 and β3 integrin mobility.

De Mets R, Wang I, Balland M, Oddou C, Moreau P, Fourcade B, Albiges-Rizo C, Delon A, Destaing O.

Mol Biol Cell. 2018 Nov 21:mbcE18040253. doi: 10.1091/mbc.E18-04-0253. [Epub ahead of print]

PMID:
30462575
8.

Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells.

Moreau PR, Örd T, Downes NL, Niskanen H, Bouvy-Liivrand M, Aavik E, Ylä-Herttuala S, Kaikkonen MU.

Front Cardiovasc Med. 2018 Nov 5;5:159. doi: 10.3389/fcvm.2018.00159. eCollection 2018.

9.

HLA-G, -E and -F regulatory and coding region variability and haplotypes in the Beninese Toffin population sample.

Sonon P, Sadissou I, Tokplonou L, M'po KKG, Glitho SSC, Agniwo P, Ibikounlé M, Massaro JD, Massougbodji A, Moreau P, Sabbagh A, Mendes-Junior CT, Moutairou KA, Castelli EC, Courtin D, Donadi EA.

Mol Immunol. 2018 Dec;104:108-127. doi: 10.1016/j.molimm.2018.08.016.

PMID:
30448608
10.

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting.

Richardson PG, San Miguel JF, Moreau P, Hajek R, Dimopoulos MA, Laubach JP, Palumbo A, Luptakova K, Romanus D, Skacel T, Kumar SK, Anderson KC.

Blood Cancer J. 2018 Nov 9;8(11):109. doi: 10.1038/s41408-018-0141-0. Review.

11.

A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.

Boutault R, Peterlin P, Boubaya M, Sockel K, Chevallier P, Garnier A, Guillaume T, Le Bourgeois A, Debord C, Godon C, Le Bris Y, Theisen O, Kroschinsky F, Moreau P, Béné MC, Platzbecker U, Eveillard M.

Br J Haematol. 2018 Dec;183(5):736-746. doi: 10.1111/bjh.15626. Epub 2018 Nov 8.

PMID:
30406952
12.

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.

Dimopoulos MA, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, Leleu X, LeBlanc R, Suzuki K, Raab MS, Richardson PG, Popa McKiver M, Jou YM, Shelat SG, Robbins M, Rafferty B, San-Miguel J.

N Engl J Med. 2018 Nov 8;379(19):1811-1822. doi: 10.1056/NEJMoa1805762.

PMID:
30403938
13.

The new magnetic diagnostics in the WEST tokamak.

Moreau P, Le-Luyer A, Spuig P, Malard P, Saint-Laurent F, Artaud JF, Morales J, Faugeras B, Heumann H, Cantone B, Moreau M, Brun C, Nouailletas R, Nardon E, Santraine B, Berne A, Kumari P, Belsare S; WEST Team.

Rev Sci Instrum. 2018 Oct;89(10):10J109. doi: 10.1063/1.5036537.

PMID:
30399836
14.

Steady state magnetic sensors for ITER and beyond: Development and final design (invited).

Kocan M, Duran I, Entler S, Vayakis G, Agostinetti P, Brombin M, Carmona JM, Gambetta G, Jirman T, Marconato N, Moreau P, Peruzzo S, Spuig P, Walsh M.

Rev Sci Instrum. 2018 Oct;89(10):10J119. doi: 10.1063/1.5038871.

PMID:
30399664
15.

Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis.

Grillon A, Scherlinger M, Boyer PH, De Martino S, Perdriger A, Blasquez A, Wipff J, Korganow AS, Bonnard C, Cantagrel A, Eyer D, Guérin F, Monteiro I, Woehl JM, Moreau P, Pennaforte JL, Lechevallier J, Bastides F, Colombey A, Imbert I, Maugars Y, Gicquel P, Cuchet F, Brax M, Sibilia J, Zilliox L, Barthel C, Arnaud L, Jaulhac B.

Semin Arthritis Rheum. 2018 Sep 28. pii: S0049-0172(18)30424-4. doi: 10.1016/j.semarthrit.2018.09.007. [Epub ahead of print]

PMID:
30344080
16.

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies.

Chevallier P, Peterlin P, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Le Bris Y, Béné MC, Le Gouill S, Moreau P, Guillaume T.

Oncotarget. 2018 Sep 11;9(71):33528-33535. doi: 10.18632/oncotarget.26083. eCollection 2018 Sep 11.

17.

Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin.

Moreau P, Cournac A, Palumbo GA, Marbouty M, Mortaza S, Thierry A, Cairo S, Lavigne M, Koszul R, Neuveut C.

Nat Commun. 2018 Oct 15;9(1):4268. doi: 10.1038/s41467-018-06739-4.

18.

BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment.

Gomez-Bougie P, Maiga S, Tessoulin B, Bourcier J, Bonnet A, Rodriguez MS, Le Gouill S, Touzeau C, Moreau P, Pellat-Deceunynck C, Amiot M.

Blood. 2018 Oct 11. pii: blood-2018-03-836718. doi: 10.1182/blood-2018-03-836718. [Epub ahead of print]

PMID:
30309889
19.

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.

Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S.

Blood Cancer J. 2018 Oct 4;8(10):95. doi: 10.1038/s41408-018-0124-1.

20.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Garderet L, Kuhnowski F, Berge B, Roussel M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A, Moreau P, Marit G, Stoppa AM, Royer B, Chaleteix C, Tiab M, Araujo C, Lenain P, Macro M, Voog E, Benboubker L, Allangba O, Jourdan E, Orsini-Piocelle F, Brechignac S, Eveillard JR, Belhadj K, Wetterwald M, Pegourie B, Jaccard A, Eisenmann JC, Glaisner S, Mohty M, Hulin C, Loiseau HA, Mathiot C, Attal M.

Blood. 2018 Dec 13;132(24):2555-2563. doi: 10.1182/blood-2018-07-863829. Epub 2018 Oct 3.

PMID:
30282798
21.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

PMID:
30249784
22.

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.

Dimopoulos MA, San-Miguel J, Belch A, White D, Benboubker L, Cook G, Leiba M, Morton J, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL, Sutherland HJ, Lalancette M, Magen H, Iida S, Kim JS, Prince HM, Cochrane T, Oriol A, Bahlis NJ, Chari A, O' Rourke L, Wu K, Schecter JM, Casneuf T, Chiu C, Soong D, Sasser AK, Khokhar NZ, Avet-Loiseau H, Usmani SZ.

Haematologica. 2018 Sep 20. pii: haematol.2018.194282. doi: 10.3324/haematol.2018.194282. [Epub ahead of print]

23.

Global Approaches in Myeloma: Critical Trials That May Change Practice.

Moreau P, Touzeau C.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):656-661. doi: 10.1200/EDBK_200841. Review.

24.

Experimental Limits of Ghost Diffraction: Popper's Thought Experiment.

Moreau PA, Morris PA, Toninelli E, Gregory T, Aspden RS, Spalding G, Boyd RW, Padgett MJ.

Sci Rep. 2018 Sep 4;8(1):13183. doi: 10.1038/s41598-018-31429-y.

25.

Genomic patterns of progression in smoldering multiple myeloma.

Bolli N, Maura F, Minvielle S, Gloznik D, Szalat R, Fullam A, Martincorena I, Dawson KJ, Samur MK, Zamora J, Tarpey P, Davies H, Fulciniti M, Shammas MA, Tai YT, Magrangeas F, Moreau P, Corradini P, Anderson K, Alexandrov L, Wedge DC, Avet-Loiseau H, Campbell P, Munshi N.

Nat Commun. 2018 Aug 22;9(1):3363. doi: 10.1038/s41467-018-05058-y.

26.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

PMID:
30098165
27.

Targeting Bcl-2 for the treatment of multiple myeloma.

Touzeau C, Maciag P, Amiot M, Moreau P.

Leukemia. 2018 Sep;32(9):1899-1907. doi: 10.1038/s41375-018-0223-9. Epub 2018 Aug 3. Review.

PMID:
30076373
28.

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.

Bailly C, Carlier T, Jamet B, Eugene T, Touzeau C, Attal M, Hulin C, Facon T, Leleu X, Perrot A, Garderet L, Macro M, Caillot D, Moreau P, Kraeber-Bodéré F, Bodet-Milin C.

Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1.

PMID:
30068709
29.

Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.

Qian X, Dimopoulos MA, Amatangelo M, Bjorklund C, Towfic F, Flynt E, Weisel KC, Ocio EM, Yu X, Peluso T, Sternas L, Zaki M, Moreau P, Thakurta A.

Leuk Lymphoma. 2018 Aug 2:1-9. doi: 10.1080/10428194.2018.1485915. [Epub ahead of print]

PMID:
30068263
30.

Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.

Norwood J, Pastoret C, Luycx O, Le Coz MF, Moreau P, Trebouet A, Niault M, Launay V, Allangba O, Bareau B, Doncker V, Grulois I, Jacomy D, Le Dû K, Henry C, Le Pabic E, Boulland ML, Fest T, Lamy T, Escoffre-Barbe M.

Am J Hematol. 2018 Oct;93(10):E329-E331. doi: 10.1002/ajh.25217. Epub 2018 Sep 30. No abstract available.

PMID:
30019460
31.

Considerations and consequences of allowing DNA sequence data as types of fungal taxa.

Zamora JC, Svensson M, Kirschner R, Olariaga I, Ryman S, Parra LA, Geml J, Rosling A, Adamčík S, Ahti T, Aime MC, Ainsworth AM, Albert L, Albertó E, García AA, Ageev D, Agerer R, Aguirre-Hudson B, Ammirati J, Andersson H, Angelini C, Antonín V, Aoki T, Aptroot A, Argaud D, Sosa BIA, Aronsen A, Arup U, Asgari B, Assyov B, Atienza V, Bandini D, Baptista-Ferreira JL, Baral HO, Baroni T, Barreto RW, Beker H, Bell A, Bellanger JM, Bellù F, Bemmann M, Bendiksby M, Bendiksen E, Bendiksen K, Benedek L, Bérešová-Guttová A, Berger F, Berndt R, Bernicchia A, Biketova AY, Bizio E, Bjork C, Boekhout T, Boertmann D, Böhning T, Boittin F, Boluda CG, Boomsluiter MW, Borovička J, Brandrud TE, Braun U, Brodo I, Bulyonkova T, Burdsall HH Jr, Buyck B, Burgaz AR, Calatayud V, Callac P, Campo E, Candusso M, Capoen B, Carbó J, Carbone M, Castañeda-Ruiz RF, Castellano MA, Chen J, Clerc P, Consiglio G, Corriol G, Courtecuisse R, Crespo A, Cripps C, Crous PW, da Silva GA, da Silva M, Dam M, Dam N, Dämmrich F, Das K, Davies L, De Crop E, De Kesel A, De Lange R, De Madrignac Bonzi B, Dela Cruz TEE, Delgat L, Demoulin V, Desjardin DE, Diederich P, Dima B, Dios MM, Divakar PK, Douanla-Meli C, Douglas B, Drechsler-Santos ER, Dyer PS, Eberhardt U, Ertz D, Esteve-Raventós F, Salazar JAE, Evenson V, Eyssartier G, Farkas E, Favre A, Fedosova AG, Filippa M, Finy P, Flakus A, Fos S, Fournier J, Fraiture A, Franchi P, Molano AEF, Friebes G, Frisch A, Fryday A, Furci G, Márquez RG, Garbelotto M, García-Martín JM, Otálora MAG, Sánchez DG, Gardiennet A, Garnica S, Benavent IG, Gates G, da Cruz Lima Gerlach A, Ghobad-Nejhad M, Gibertoni TB, Grebenc T, Greilhuber I, Grishkan B, Groenewald JZ, Grube M, Gruhn G, Gueidan C, Gulden G, Gusmão LF, Hafellner J, Hairaud M, Halama M, Hallenberg N, Halling RE, Hansen K, Harder CB, Heilmann-Clausen J, Helleman S, Henriot A, Hernandez-Restrepo M, Herve R, Hobart C, Hoffmeister M, Høiland K, Holec J, Holien H, Hughes K, Hubka V, Huhtinen S, Ivančević B, Jagers M, Jaklitsch W, Jansen A, Jayawardena RS, Jeppesen TS, Jeppson M, Johnston P, Jørgensen PM, Kärnefelt I, Kalinina LB, Kantvilas G, Karadelev M, Kasuya T, Kautmanová I, Kerrigan RW, Kirchmair M, Kiyashko A, Knapp DG, Knudsen H, Knudsen K, Knutsson T, Kolařík M, Kõljalg U, Košuthová A, Koszka A, Kotiranta H, Kotkova V, Koukol O, Kout J, Kovács GM, Kříž M, Kruys Å, Kučera V, Kudzma L, Kuhar F, Kukwa M, Arun Kumar TK, Kunca V, Kušan I, Kuyper TW, Lado C, Læssøe T, Lainé P, Langer E, Larsson E, Larsson KH, Laursen G, Lechat C, Lee S, Lendemer JC, Levin L, Lindemann U, Lindström H, Liu X, Hernandez RCL, Llop E, Locsmándi C, Lodge DJ, Loizides M, Lőkös L, Luangsa-Ard J, Lüderitz M, Lumbsch T, Lutz M, Mahoney D, Malysheva E, Malysheva V, Manimohan P, Marin-Felix Y, Marques G, Martínez-Gil R, Marson G, Mata G, Matheny PB, Mathiassen GH, Matočec N, Mayrhofer H, Mehrabi M, Melo I, Mešić A, Methven AS, Miettinen O, Romero AMM, Miller AN, Mitchell JK, Moberg R, Moreau PA, Moreno G, Morozova O, Morte A, Muggia L, González GM, Myllys L, Nagy I, Nagy LG, Neves MA, Niemelä T, Nimis PL, Niveiro N, Noordeloos ME, Nordin A, Noumeur SR, Novozhilov Y, Nuytinck J, Ohenoja E, Fiuza PO, Orange A, Ordynets A, Ortiz-Santana B, Pacheco L, Pál-Fám F, Palacio M, Palice Z, Papp V, Pärtel K, Pawlowska J, Paz A, Peintner U, Pennycook S, Pereira OL, Daniëls PP, Pérez-De-Gregorio Capella MÀ, Del Amo CMP, Gorjón SP, Pérez-Ortega S, Pérez-Vargas I, Perry BA, Petersen JH, Petersen RH, Pfister DH, Phukhamsakda C, Piątek M, Piepenbring M, Pino-Bodas R, Esquivel JPP, Pirot P, Popov ES, Popoff O, Álvaro MP, Printzen C, Psurtseva N, Purahong W, Quijada L, Rambold G, Ramírez NA, Raja H, Raspé O, Raymundo T, Réblová M, Rebriev YA, de Dios Reyes García J, Ripoll MÁR, Richard F, Richardson MJ, Rico VJ, Robledo GL, Barbosa FR, Rodriguez-Caycedo C, Rodriguez-Flakus P, Ronikier A, Casas LR, Rusevska K, Saar G, Saar I, Salcedo I, Martínez SMS, Montoya CAS, Sánchez-Ramírez S, Sandoval-Sierra JV, Santamaria S, Monteiro JS, Schroers HJ, Schulz B, Schmidt-Stohn G, Schumacher T, Senn-Irlet B, Ševčíková H, Shchepin O, Shirouzu T, Shiryaev A, Siepe K, Sir EB, Sohrabi M, Soop K, Spirin V, Spribille T, Stadler M, Stalpers J, Stenroos S, Suija A, Sunhede S, Svantesson S, Svensson S, Svetasheva TY, Świerkosz K, Tamm H, Taskin H, Taudière A, Tedebrand JO, Lahoz RT, Temina M, Thell A, Thines M, Thor G, Thüs H, Tibell L, Tibell S, Timdal E, Tkalčec Z, Tønsberg T, Trichies G, Triebel D, Tsurykau A, Tulloss RE, Tuovinen V, Sosa MU, Urcelay C, Valade F, Garza RV, van den Boom P, Van Vooren N, Vasco-Palacios AM, Vauras J, Velasco Santos JM, Vellinga E, Verbeken A, Vetlesen P, Vizzini A, Voglmayr H, Volobuev S, von Brackel W, Voronina E, Walther G, Watling R, Weber E, Wedin M, Weholt Ø, Westberg M, Yurchenko E, Zehnálek P, Zhang H, Zhurbenko MP, Ekman S.

IMA Fungus. 2018 Jun;9(1):167-175. doi: 10.5598/imafungus.2018.09.01.10. Epub 2018 May 24.

32.

The multistress-induced Translocator protein (TSPO) differentially modulates storage lipids metabolism in seeds and seedlings.

Jurkiewicz P, Melser S, Maucourt M, Ayeb H, Veljanovski V, Maneta-Peyret L, Hooks M, Rolin D, Moreau P, Batoko H.

Plant J. 2018 Oct;96(2):274-286. doi: 10.1111/tpj.14028. Epub 2018 Aug 16.

PMID:
30003614
33.

Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials.

Chari A, Stewart AK, Russell SD, Moreau P, Herrmann J, Banchs J, Hajek R, Groarke J, Lyon AR, Batty GN, Ro S, Huang M, Iskander KS, Lenihan D.

Blood Adv. 2018 Jul 10;2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.

34.

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan G.

Leukemia. 2018 Jul 2. doi: 10.1038/s41375-018-0196-8. [Epub ahead of print]

PMID:
29967379
35.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM.

Lancet Haematol. 2018 Nov;5(11):e563-e598. doi: 10.1016/S2352-3026(18)30051-6. Epub 2018 Jun 18. Review.

PMID:
29907552
36.

Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.

Peterlin P, Guillaume T, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Gallas P, Touzeau C, Gastinne T, Lok A, Thomare P, Chauvin C, Le Gouill S, Moreau P, Chevallier P.

Leuk Res Rep. 2018 Jan 17;9:16-17. doi: 10.1016/j.lrr.2018.01.002. eCollection 2018. No abstract available.

37.

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, Rosenthal A, Wang H, Qu P, Hoering A, Samur M, Towfic F, Ortiz M, Flynt E, Yu Z, Yang Z, Rozelle D, Obenauer J, Trotter M, Auclair D, Keats J, Bolli N, Fulciniti M, Szalat R, Moreau P, Durie B, Stewart AK, Goldschmidt H, Raab MS, Einsele H, Sonneveld P, San Miguel J, Lonial S, Jackson GH, Anderson KC, Avet-Loiseau H, Munshi N, Thakurta A, Morgan GJ.

Blood. 2018 Aug 9;132(6):587-597. doi: 10.1182/blood-2018-03-840132. Epub 2018 Jun 8. Erratum in: Blood. 2018 Sep 27;132(13):1461.

38.

Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.

Moreau P, Mateos MV, Berenson JR, Weisel K, Lazzaro A, Song K, Dimopoulos MA, Huang M, Zahlten-Kumeli A, Stewart AK.

Lancet Oncol. 2018 Jul;19(7):953-964. doi: 10.1016/S1470-2045(18)30354-1. Epub 2018 Jun 1. Erratum in: Lancet Oncol. 2018 Aug;19(8):e382.

PMID:
29866475
39.

Clinical pharmacy in Kuwait: Services provided, perceptions and barriers.

Lemay J, Waheedi M, Al-Taweel D, Bayoud T, Moreau P.

Saudi Pharm J. 2018 May;26(4):481-486. doi: 10.1016/j.jsps.2018.02.011. Epub 2018 Feb 9.

40.

De novo biosynthesis of sterols and fatty acids in the Trypanosoma brucei procyclic form: Carbon source preferences and metabolic flux redistributions.

Millerioux Y, Mazet M, Bouyssou G, Allmann S, Kiema TR, Bertiaux E, Fouillen L, Thapa C, Biran M, Plazolles N, Dittrich-Domergue F, Crouzols A, Wierenga RK, Rotureau B, Moreau P, Bringaud F.

PLoS Pathog. 2018 May 29;14(5):e1007116. doi: 10.1371/journal.ppat.1007116. eCollection 2018 May.

41.

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.

Bolli N, Biancon G, Moarii M, Gimondi S, Li Y, de Philippis C, Maura F, Sathiaseelan V, Tai YT, Mudie L, O'Meara S, Raine K, Teague JW, Butler AP, Carniti C, Gerstung M, Bagratuni T, Kastritis E, Dimopoulos M, Corradini P, Anderson KC, Moreau P, Minvielle S, Campbell PJ, Papaemmanuil E, Avet-Loiseau H, Munshi NC.

Leukemia. 2018 Dec;32(12):2604-2616. doi: 10.1038/s41375-018-0037-9. Epub 2018 May 22.

42.

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

Dumontet C, Hulin C, Dimopoulos MA, Belch A, Dispenzieri A, Ludwig H, Rodon P, Van Droogenbroeck J, Qiu L, Cavo M, Van de Velde A, Lahuerta JJ, Allangba O, Lee JH, Boyle E, Perrot A, Moreau P, Manier S, Attal M, Roussel M, Mohty M, Mary JY, Civet A, Costa B, Tinel A, Gaston-Mathé Y, Facon T.

Leukemia. 2018 Jun;32(6):1404-1413. doi: 10.1038/s41375-018-0133-x. Epub 2018 Apr 26.

43.

A Combinatorial Lipid Code Shapes the Electrostatic Landscape of Plant Endomembranes.

Platre MP, Noack LC, Doumane M, Bayle V, Simon MLA, Maneta-Peyret L, Fouillen L, Stanislas T, Armengot L, Pejchar P, Caillaud MC, Potocký M, Čopič A, Moreau P, Jaillais Y.

Dev Cell. 2018 May 21;45(4):465-480.e11. doi: 10.1016/j.devcel.2018.04.011. Epub 2018 May 10.

PMID:
29754803
44.

Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma.

Samur MK, Minvielle S, Gulla A, Fulciniti M, Cleynen A, Aktas Samur A, Szalat R, Shammas M, Magrangeas F, Tai YT, Auclair D, Keats J, Richardson P, Attal M, Moreau P, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC.

Leukemia. 2018 Dec;32(12):2626-2635. doi: 10.1038/s41375-018-0116-y. Epub 2018 Mar 29.

45.

Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma.

Hari P, Lin HM, Zhu Y, Berg D, Richardson PG, Moreau P.

J Med Econ. 2018 Aug;21(8):793-798. doi: 10.1080/13696998.2018.1474745. Epub 2018 May 29.

PMID:
29741409
46.

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.

Leleu X, Masszi T, Bahlis NJ, Viterbo L, Baker B, Gimsing P, Maisnar V, Samoilova O, Rosiñol L, Langer C, Song K, Izumi T, Cleeland C, Berg D, Lin HM, Zhu Y, Skacel T, Moreau P, Richardson PG.

Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25134. [Epub ahead of print]

PMID:
29726031
47.

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Bladé J, Sonneveld P.

Leukemia. 2018 Jul;32(7):1542-1560. doi: 10.1038/s41375-018-0040-1. Epub 2018 May 2. Review.

48.

Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients.

Jamet B, Bailly C, Carlier T, Planche L, Touzeau C, Kraeber-Bodéré F, Moreau P, Bodet-Milin C.

Leuk Lymphoma. 2018 May 2:1-4. doi: 10.1080/10428194.2018.1459602. [Epub ahead of print] No abstract available.

PMID:
29717914
49.

New airtight transfer box for SEM experiments: Application to lithium and sodium metals observation and analyses.

Stephant N, Grissa R, Guillou F, Bretaudeau M, Borjon-Piron Y, Guillet J, Moreau P.

Micron. 2018 Jul;110:10-17. doi: 10.1016/j.micron.2018.04.003. Epub 2018 Apr 18.

PMID:
29689433
50.

The genetic diversity within the 1.4 kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses.

Dias FC, Bertol BC, Poras I, Souto BM, Mendes-Junior CT, Castelli EC, Gineau L, Sabbagh A, Rouas-Freiss N, Carosella ED, Donadi EA, Moreau P.

Sci Rep. 2018 Apr 4;8(1):5652. doi: 10.1038/s41598-018-24009-7.

Supplemental Content

Loading ...
Support Center